Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Erwann P. Loret"'
Autor:
Sonia Mediouni, Krishna Chinthalapudi, Mary K. Ekka, Ippei Usui, Joseph A. Jablonski, Mark A. Clementz, Guillaume Mousseau, Jason Nowak, Venkat R. Macherla, Jacob N. Beverage, Eduardo Esquenazi, Phil Baran, Ian Mitchelle S. de Vera, Douglas Kojetin, Erwann P. Loret, Kendall Nettles, Souvik Maiti, Tina Izard, Susana T. Valente
Publikováno v:
mBio, Vol 10, Iss 1 (2019)
ABSTRACT The intrinsically disordered HIV-1 Tat protein binds the viral RNA transactivation response structure (TAR), which recruits transcriptional cofactors, amplifying viral mRNA expression. Limited Tat transactivation correlates with HIV-1 latenc
Externí odkaz:
https://doaj.org/article/602de632323a423fab4a3dba4bf5eaf7
Autor:
Herminia Dominguez, Erwann P. Loret
Publikováno v:
Marine Drugs, Vol 17, Iss 6, p 357 (2019)
Ulva lactuca is a green macro alga involved in devastating green tides observed worldwide. These green tides or blooms are a consequence of human activities. Ulva blooms occur mainly in shallow waters and the decomposition of this alga can produce da
Externí odkaz:
https://doaj.org/article/bb038bea418e4c16b2abfce0690128fc
Autor:
Erwann P. Loret, Albert Darque, Elvenn A. Loret, Corinne Nicolino-Brunet, Sophie Morange, Elisabeth Castagnier, Josiane Casanova, Christine Caloustian, Charléric Bornet, Julie Coussirou, Jihen Bousseta, Bertrand Dussol, Isabelle Ravaux
Publikováno v:
Journal of Virus Eradication, Vol 2, Iss , Pp 39- (2016)
Externí odkaz:
https://doaj.org/article/2f6cc72f06ae4c6cac69dcac1af79c5c
Autor:
Erwann P. Loret, José Luis, Christopher Nuccio, Claude Villard, Pascal Mansuelle, Régine Lebrun, Pierre Henri Villard
Publikováno v:
Marine Drugs, Vol 16, Iss 4, p 134 (2018)
Sea anemones are a remarkable source of active principles due to a decentralized venom system. New blood vessel growth or angiogenesis is a very promising target against cancer, but the few available antiangiogenic compounds have limited efficacy. In
Externí odkaz:
https://doaj.org/article/f55f88ae0748401d861a667ba78c16a2
Autor:
Krishna Chinthalapudi, Douglas J. Kojetin, Jacob Neal Beverage, Souvik Maiti, Sonia Mediouni, Erwann P. Loret, Guillaume Mousseau, Ippei Usui, Tina Izard, Susana T. Valente, Jason Nowak, Kendall W. Nettles, Ian Mitchelle S. de Vera, Joseph A. Jablonski, Eduardo Esquenazi, Venkat R. Macherla, Phil S. Baran, Mark A. Clementz, Mary Krishna Ekka
Publikováno v:
mBio, Vol 10, Iss 1, p e02662-18 (2019)
mBio, Vol 10, Iss 1 (2019)
mBio
mBio, Vol 10, Iss 1 (2019)
mBio
Tat activates virus production, and limited Tat transactivation correlates with HIV-1 latency. The Tat inhibitor dCA locks HIV in persistent latency. This drug class enables block-and-lock functional cure approaches, aimed at reducing residual viremi
Autor:
Marjorie Robert-Guroff, Erwann P. Loret, James G. Else, Sandra J. Lee, Robert A. Rasmussen, Donald N. Forthal, Shannon Stock, Francois Villinger, Mingkui Zhou, Barbara C. Bachler, Victoria R. Polonis, Ruth M. Ruprecht, Welkin E. Johnson, Diego A. Vargas-Inchaustegui, Egidio Brocca Cofano, Girish Hemashettar, Siddappa N. Byrareddy, Shiu Lok Hu, Samir K. Lakhashe
Publikováno v:
Vaccine. 32:6527-6536
We sought to test whether vaccine-induced immune responses could protect rhesus macaques (RMs) against upfront heterologous challenges with an R5 simian-human immunodeficiency virus, SHIV-2873Nip. This SHIV strain exhibits many properties of transmit
Autor:
Christian Devaux, Sonia Mediouni, Albert Darque, Erwann P. Loret, Gilbert Baillat, Isabelle Ravaux
Publikováno v:
Journal of Biological Chemistry. 288:19072-19080
Extracellular Tat is suspected to protect HIV-1-infected cells from cellular immunity. Seropositive patients are unable to produce neutralizing antibodies against Tat, and Tat is still secreted under antiviral treatment. In mice, the Tat OYI vaccine
Autor:
Erwann P. Loret, Olfa Kallech-Ziri, Naziha Marrakchi, Amine Bazaa, Sofiane Bezzine, Najet Srairi-Abid, Aida Karray, José Luis, Raoudha Zouari-Kessentini, Mohamed El Ayeb
Publikováno v:
Toxicon
Toxicon, Elsevier, 2009, 53 (4), pp.444-53. ⟨10.1016/j.toxicon.2009.01.003⟩
Toxicon, Elsevier, 2009, 53 (4), pp.444-53. ⟨10.1016/j.toxicon.2009.01.003⟩
International audience; Two non-toxic PLA2s were purified to homogeneity from Cerastes cerastes Tunisian snake venom. The purification process employed gel filtration on Sephadex G-75 followed by C18 reverse phase high-pressure liquid chromatography.
Autor:
Erwann P. Loret
Publikováno v:
Current HIV research. 13(2)
The human immunodeficiency virus type 1 (HIV) eradication will require elimination of HIV infected cells. No antiretroviral treatments (ART) or vaccine approaches have been able to reduce significantly the level of HIV infected cells in peripheral bl
Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells
Autor:
Françoise Sanchez, Bruno Beaumelle, Solène Debaisieux, Clément Mettling, Yea-Lih Lin, Fabienne Rayne, Anne Bonhoure, Laurence Briant, Nathalie Chazal, Hocine Yezid, Erwann P. Loret, Christian Roy, Martine Pugnière, Stefan T. Arold, Karidia Konate
Publikováno v:
EMBO Journal
EMBO Journal, EMBO Press, 2010, 29 (8), pp.1348-1362. ⟨10.1038/emboj.2010.32⟩
EMBO Journal, 2010, 29 (8), pp.1348-1362. ⟨10.1038/emboj.2010.32⟩
EMBO Journal, EMBO Press, 2010, 29 (8), pp.1348-1362. ⟨10.1038/emboj.2010.32⟩
EMBO Journal, 2010, 29 (8), pp.1348-1362. ⟨10.1038/emboj.2010.32⟩
International audience; Human immunodeficiency virus type 1 (HIV-1) transcription relies on its transactivating Tat protein. Although devoid of a signal sequence, Tat is released by infected cells and secreted Tat can affect uninfected cells, thereby
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4354dd2a3ae446c007eff4335d1dc9d
https://hal.archives-ouvertes.fr/hal-02147182/document
https://hal.archives-ouvertes.fr/hal-02147182/document